Skip to main content

Pathway Capital Management, LP

SEC CIK
0001037353
Latest filing
Aug 3, 2026

Holdings in Q4 2022

Holdings as of Dec 31, 2022, filed Feb 10, 2023. Long positions only; changes compare share counts with Q3 2022.

Institution overview
Positions
6
+3 vs. Q3 2022
Portfolio value
$56.0M
+$24.8M (+79.6%) vs. Q3 2022
Filed
Feb 10, 2023
SEC
Holdings of Pathway Capital Management, LP in Q4 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
DAWNDay One Biopharmaceuticals, Inc.Stock995,686$21.4M38.2%+592,559+147.0%AddedHistory
TOSTToast, Inc.Stock1,168,871$21.1M37.6%00.0%UnchangedHistory
ACLXArcellx, Inc.COMMON STOCK189,120$5.86M10.5%+189,120NewHistory
AVEOAveo Pharmaceuticals, Inc.COM NEW245,606$3.67M6.6%+245,606NewHistory
TDGTransDigm Group INCCOM4,530$2.85M5.1%+4,530NewHistory
FLYWFlywire CorpCOM VTG46,960$1.15M2.1%+46,960NewHistory

Sold out since Q3 2022 (1)

Positions held at the end of Q3 2022 that are gone from this filing.

Positions of Pathway Capital Management, LP sold out since Q3 2022
SecurityClassShares in Q3 2022Value in Q3 2022% of portfolio in Q3 2022History
DUOLDuolingo, Inc.CL A COM9,236$880.0K2.8%History